Indian equity benchmarks ended the week marginally lower amid sustained FII outflows and US-India trade uncertainty, though sentiment improved after a US Fed rate cut. The Nifty reclaimed key technical levels, while autos and metals led gains. Global cues, currency moves and earnings outlook remain crucial.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026